Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...

Ocugen (OCGN) announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema, DME. “OCU200 has ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

What are the signs that show I need cataract surgery? "There are several key signs that someone may need cataract surgery," explains Dr. Levenson. These include: Blurry or cloudy vision that makes ...

Retinal Biologics Industry. The retinal biologics market experienced significant growth in 2021, with total revenue reaching ...

To participate, users can access the Jupiter Airdrop Checker directly within the Bitget Wallet app's Discover section. By ...

Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...

For those who struggle with insurance or can’t afford cutting-edge health care, there’s an eye-opening opportunity coming to ...